Trial intelligence / Profile preview

Transcriptional Profiling of Endometrial Biopsies After GnRH Agonist or hCG Trigger

NCT01606709Phase 4Terminated

Sponsor
UConn Health
Start
Apr 2012
Primary completion
Dec 2014
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of leuprolide in ovarian hyperstimulation syndrome (OHSS), sponsored by UConn Health. Started Apr 2012; status: terminated.

02

Drugs

leuprolide
03

Conditions

ovarian hyperstimulation syndrome (OHSS)

Beyond the preview

Go deeper on NCT01606709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01606709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call